Does Ibuprofen Worsen COVID-19?

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

(2020) Jin-jin Zhang et al.   ALLERGY

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

(2020) Yushun Wan et al.   JOURNAL OF VIROLOGY

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

(2020) Xiaobo Yang et al.   Lancet Respiratory Medicine

COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?

(2020) Gurusaravanan Kutti Sridharan et al.   AMERICAN JOURNAL OF THERAPEUTICS

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Safety of Ibuprofen in Patients With COVID-19

(2020) Mohit Sodhi et al.   CHEST

A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias

(2020) Dahai Zhao et al.   CLINICAL INFECTIOUS DISEASES

Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

(2020) Gianluca Trifirò et al.   DRUG SAFETY

Chloroquine for COVID-19 Infection

(2020) Nicholas Moore   DRUG SAFETY

SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

(2020) Gabriela M Kuster et al.   EUROPEAN HEART JOURNAL

Clinical features and treatment of COVID-19 patients in northeast Chongqing

(2020) Suxin Wan et al.   JOURNAL OF MEDICAL VIROLOGY

COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments

(2020) Oliver Zolk et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom

(2020) Sheng-Chia Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19

(2020) John A. Jarcho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

(2020) Giuseppe Mancia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

(2020) Harmony R. Reynolds et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

(2020) Muthiah Vaduganathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Considerations for pharmacoepidemiological analyses in the SARS‐CoV ‐2 pandemic

(2020) Anton Pottegård et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Covid-19: European drugs agency to review safety of ibuprofen

(2020) Michael Day   BMJ-British Medical Journal

Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear

(2020) Ingrid Torjesen   BMJ-British Medical Journal

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists

(2020) Michael Day   BMJ-British Medical Journal

Non-steroidal anti-inflammatory drugs and covid-19

(2020) Paul Little   BMJ-British Medical Journal

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients

(2019) Guillaume Voiriot et al.   Journal of Clinical Medicine

Nonsteroidal Antiinflammatory Drug Use and Clinical Outcomes of Community-acquired Pneumonia

(2018) Damien Basille et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study

(2018) Sinem Ezgi Gulmez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System

(2018) Nicholas Moore et al.   DRUG SAFETY

Usage patterns of paracetamol in France

(2016) Mai Duong et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Liver transplant associated with paracetamol overdose: results from the seven-country SALT study

(2015) Sinem Ezgi Gulmez et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Ibuprofen Attenuates Cardiac Fibrosis in Streptozotocin-Induced Diabetic Rats

(2015) Weili Qiao et al.   CARDIOLOGY

Usage patterns of ‘over-the-counter’vs. prescription-strength nonsteroidal anti-inflammatory drugs in France

(2013) Mai Duong et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen)

(2013) Sinem Ezgi Gulmez et al.   DRUG SAFETY

Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial

(2013) P. Little et al.   BMJ-British Medical Journal